Replimune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. 

CEO
Sushil Patel
CEOSushil Patel
Employees
465
Employees465
Headquarters
Woburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded
2015
Founded2015
Employees
465
Employees465

REPL Key Statistics

Market cap
1.25B
Market cap1.25B
Price-Earnings ratio
-4.04
Price-Earnings ratio-4.04
Dividend yield
—
Dividend yield—
Average volume
2.42M
Average volume2.42M
High today
$13.51
High today$13.51
Low today
$12.87
Low today$12.87
Open price
$13.18
Open price$13.18
Volume
2.62M
Volume2.62M
52 Week high
$16.33
52 Week high$16.33
52 Week low
$1.50
52 Week low$1.50

Stock Snapshot

The current Replimune(REPL) stock price is $13.10, with a market capitalization of 1.25B. The stock trades at a price-to-earnings (P/E) ratio of -4.04.

As of 2026-10-06, Replimune(REPL) stock has fluctuated between $12.87 and $13.51. The current price stands at $13.10, placing the stock +1.8% above today's low and -3.0% off the high.

The Replimune(REPL)'s current trading volume is 2.62M, compared to an average daily volume of 2.42M.

During the past year, Replimune(REPL) stock moved between $1.50 at its lowest and $16.33 at its peak.

During the past year, Replimune(REPL) stock moved between $1.50 at its lowest and $16.33 at its peak.

REPL News

Simply Wall St 4d
Is Replimune Group Undervalued On Its TUDRIQEV Revenue Story?

Replimune Group (REPL) has drawn fresh attention after recent trading left the stock at $13.45. Sharp swings over the past month and past 3 months have put its...

Is Replimune Group Undervalued On Its TUDRIQEV Revenue Story?

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.